Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Comment on: 'Antibiotic footprint' as a communication tool to aid reduction of antibiotic consumption.

Gould IM, Nebot C, Aldeyab M, López-Lozano JM.

J Antimicrob Chemother. 2019 Nov 23. pii: dkz496. doi: 10.1093/jac/dkz496. [Epub ahead of print] No abstract available.

PMID:
31758689
2.

Challenges and opportunities for antimicrobial stewardship in resource-rich and resource-limited countries.

Hijazi K, Joshi C, Gould IM.

Expert Rev Anti Infect Ther. 2019 Aug;17(8):621-634. doi: 10.1080/14787210.2019.1640602. Epub 2019 Jul 15.

PMID:
31282277
3.

Antibacterials in the pipeline and perspectives for the near future.

Gould IM, Gunasekera C, Khan A.

Curr Opin Pharmacol. 2019 Oct;48:69-75. doi: 10.1016/j.coph.2019.05.001. Epub 2019 Jun 11. Review.

PMID:
31200170
4.

New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship.

Jean SS, Gould IM, Lee WS, Hsueh PR; International Society of Antimicrobial Chemotherapy (ISAC).

Drugs. 2019 May;79(7):705-714. doi: 10.1007/s40265-019-01112-1. Review.

PMID:
30972660
5.

A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

López-Lozano JM, Lawes T, Nebot C, Beyaert A, Bertrand X, Hocquet D, Aldeyab M, Scott M, Conlon-Bingham G, Farren D, Kardos G, Fésűs A, Rodríguez-Baño J, Retamar P, Gonzalo-Jiménez N, Gould IM; THRESHOLDS study group.

Nat Microbiol. 2019 Jul;4(7):1160-1172. doi: 10.1038/s41564-019-0410-0. Epub 2019 Apr 8.

PMID:
30962570
6.

Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.

Zamudio R, Hijazi K, Joshi C, Aitken E, Oggioni MR, Gould IM.

Int J Antimicrob Agents. 2019 Jun;53(6):774-780. doi: 10.1016/j.ijantimicag.2019.02.022. Epub 2019 Mar 2.

PMID:
30831233
7.

Time for biocide stewardship?

Zamudio R, Oggioni MR, Gould IM, Hijazi K.

Nat Microbiol. 2019 May;4(5):732-733. doi: 10.1038/s41564-019-0360-6. No abstract available.

PMID:
30804541
8.

An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC).

Saeed K, Bal AM, Gould IM, David MZ, Dryden M, Giannitsioti E, Hijazi K, Meisner JA, Esposito S, Scaglione F, Tattevin P, Voss A.

Int J Antimicrob Agents. 2019 Jan;53(1):9-15. doi: 10.1016/j.ijantimicag.2018.09.014. Epub 2018 Sep 19. No abstract available.

PMID:
30240836
9.

Current and future treatment options for community-associated MRSA infection.

Khan A, Wilson B, Gould IM.

Expert Opin Pharmacother. 2018 Apr;19(5):457-470. doi: 10.1080/14656566.2018.1442826. Epub 2018 Feb 26. Review.

PMID:
29480032
10.

Decision and cost analysis of empirical antibiotic therapy of acute sinusitis in the era of increasing antimicrobial resistance: do we have an additional tool for antibiotic policy decisions?

Babela R, Jarcuska P, Uraz V, Krčméry V, Jadud B, Stevlik J, Gould IM.

Neuro Endocrinol Lett. 2017 Nov;38(Suppl1):9-26. Review.

PMID:
29200249
11.

Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.

Bal AM, David MZ, Garau J, Gottlieb T, Mazzei T, Scaglione F, Tattevin P, Gould IM.

J Glob Antimicrob Resist. 2017 Sep;10:295-303. doi: 10.1016/j.jgar.2017.05.019. Epub 2017 Jul 18. Review.

PMID:
28732783
12.

Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.

David MZ, Dryden M, Gottlieb T, Tattevin P, Gould IM.

Int J Antimicrob Agents. 2017 Sep;50(3):303-307. doi: 10.1016/j.ijantimicag.2017.05.006. Epub 2017 Jun 27. Review.

13.

Editorial.

Stefani S, Xu YC, Hsueh PR, Gould IM.

J Glob Antimicrob Resist. 2017 Mar;8:A1. doi: 10.1016/j.jgar.2017.02.001. Epub 2017 Mar 4. No abstract available.

PMID:
28377106
14.

Interventions to improve antibiotic prescribing practices for hospital inpatients.

Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, Gould IM, Ramsay CR, Michie S.

Cochrane Database Syst Rev. 2017 Feb 9;2:CD003543. doi: 10.1002/14651858.CD003543.pub4. Review.

15.

Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.

McCool R, Gould IM, Eales J, Barata T, Arber M, Fleetwood K, Glanville J, Kauf TL.

BMC Infect Dis. 2017 Jan 7;17(1):39. doi: 10.1186/s12879-016-2100-3.

16.

Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.

Lawes T, Lopez-Lozano JM, Nebot CA, Macartney G, Subbarao-Sharma R, Wares KD, Sinclair C, Gould IM.

Lancet Infect Dis. 2017 Feb;17(2):194-206. doi: 10.1016/S1473-3099(16)30397-8. Epub 2016 Nov 4.

PMID:
27825595
17.

Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.

Abbott FK, Milne KE, Stead DA, Gould IM.

Int J Antimicrob Agents. 2016 Nov;48(5):521-527. doi: 10.1016/j.ijantimicag.2016.07.020. Epub 2016 Sep 12.

PMID:
27665523
18.

Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections.

Hijazi K, Mukhopadhya I, Abbott F, Milne K, Al-Jabri ZJ, Oggioni MR, Gould IM.

Int J Antimicrob Agents. 2016 Jul;48(1):86-90. doi: 10.1016/j.ijantimicag.2016.04.015. Epub 2016 May 17.

PMID:
27230473
19.

Reduced penicillin susceptibility of group B Streptococcus: an assessment of emergence in Grampian, Scotland.

Cooper K, Abbott F, Gould IM.

Br J Biomed Sci. 2016;73(1):25-7. doi: 10.1080/09674845.2016.1144550. Epub 2016 Mar 11. No abstract available.

PMID:
27182673
20.

Role of old antimicrobial agents in the management of urinary tract infection.

El Sakka N, Gould IM.

Expert Rev Clin Pharmacol. 2016 Aug;9(8):1047-56. doi: 10.1080/17512433.2016.1189325. Epub 2016 May 31. Review.

PMID:
27171243
21.

Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.

Browne C, Muszbek N, Chapman R, Marsh K, Gould IM, Seaton RA, Allen M.

Int J Antimicrob Agents. 2016 May;47(5):357-61. doi: 10.1016/j.ijantimicag.2016.02.006. Epub 2016 Mar 19.

PMID:
27061774
22.

Antibiotic stewardship: prescribing social norms.

Gould IM, Lawes T.

Lancet. 2016 Apr 23;387(10029):1699-701. doi: 10.1016/S0140-6736(16)00007-6. Epub 2016 Feb 18. No abstract available.

23.

Antibiotic Stewardship: What's Not To Like?

Gould IM.

Eur Urol. 2016 Feb;69(2):284-5. doi: 10.1016/j.eururo.2015.09.029. Epub 2015 Oct 2. No abstract available.

PMID:
26439887
24.

Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.

Lawes T, Lopez-Lozano JM, Nebot CA, Macartney G, Subbarao-Sharma R, Dare CR, Wares KD, Gould IM.

Lancet Infect Dis. 2015 Dec;15(12):1438-49. doi: 10.1016/S1473-3099(15)00315-1. Epub 2015 Sep 25. Erratum in: Lancet Infect Dis. 2016 Jan;16(1):16.

PMID:
26411518
25.

Are all Staphylococcus aureus equal?

Lawes T, Edwards B, Gould IM.

Lancet Infect Dis. 2015 Jul;15(7):762. doi: 10.1016/S1473-3099(15)00060-2. No abstract available.

PMID:
26122442
26.

Turning the tide or riding the waves? Impacts of antibiotic stewardship and infection control on MRSA strain dynamics in a Scottish region over 16 years: non-linear time series analysis.

Lawes T, López-Lozano JM, Nebot C, Macartney G, Subbarao-Sharma R, Dare CR, Edwards GF, Gould IM.

BMJ Open. 2015 Mar 26;5(3):e006596. doi: 10.1136/bmjopen-2014-006596.

27.

Community-acquired pneumonia.

Tattevin P, Levy Hara G, Gould IM.

N Engl J Med. 2015 Jan 15;372(3):293. doi: 10.1056/NEJMc1414306. No abstract available.

PMID:
25587966
28.

Childbed fever: history repeats itself?

Graham WJ, Dancer SJ, Gould IM, Stones W.

BJOG. 2015 Jan;122(2):156-9. doi: 10.1111/1471-0528.13189. No abstract available.

29.

An international cross-sectional survey of antimicrobial stewardship programmes in hospitals.

Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, Nathwani D; ESCMID Study Group for Antimicrobial Policies (ESGAP); ISC Group on Antimicrobial Stewardship.

J Antimicrob Chemother. 2015 Apr;70(4):1245-55. doi: 10.1093/jac/dku497. Epub 2014 Dec 18.

PMID:
25527272
30.

Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?

Edwards B, Andini R, Esposito S, Grossi P, Lew D, Mazzei T, Novelli A, Soriano A, Gould IM.

J Glob Antimicrob Resist. 2014 Sep;2(3):133-140. doi: 10.1016/j.jgar.2014.03.009. Epub 2014 May 29. Review.

PMID:
27873719
31.

Combination testing of colistin with telavancin and daptomycin.

Milne KE, Gould IM.

J Antimicrob Chemother. 2014 Dec;69(12):3440-1. doi: 10.1093/jac/dku287. Epub 2014 Jul 30. No abstract available.

PMID:
25077490
32.

Using daptomycin in hospitalised patients with cSSTI caused by Staphylococcus aureus has an impact on costs.

Muszbek N, Chapman R, Browne C, Marsh K, Gould IM, Brown RE, Balp MM, Allen M.

Chemotherapy. 2013;59(6):427-34. doi: 10.1159/000363280. Epub 2014 Jul 19.

PMID:
25060342
33.

A cross-sectional survey of antimicrobial stewardship strategies in UK hospitals.

Tonna AP, Gould IM, Stewart D.

J Clin Pharm Ther. 2014 Oct;39(5):516-20. doi: 10.1111/jcpt.12181. Epub 2014 May 29.

PMID:
24890879
34.

MDRO Beijing Consensus Meeting Report: Global burden of multidrug-resistant organisms' current antimicrobial resistance problems in Asia-Pacific.

Gould IM, Wang GQ, Wu JJ, Lim VK, Hutchinson J, Walsh T, Turnidge J.

J Glob Antimicrob Resist. 2014 Mar;2(1):7-9. doi: 10.1016/j.jgar.2013.10.005. Epub 2013 Nov 8. Review.

PMID:
27873642
35.

Does vancomycin have a future in the treatment of skin infections?

O'Brien DJ, Gould IM.

Curr Opin Infect Dis. 2014 Apr;27(2):146-54. doi: 10.1097/QCO.0000000000000048. Review.

PMID:
24526063
36.

Antibiotic resistance-the need for global solutions.

Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O.

Lancet Infect Dis. 2013 Dec;13(12):1057-98. doi: 10.1016/S1473-3099(13)70318-9. Epub 2013 Nov 17. Erratum in: Lancet Infect Dis. 2014 Jan;14(1):11. Lancet Infect Dis. 2014 Mar;14(3):182.

PMID:
24252483
37.

Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.

Gould IM, Miró JM, Rybak MJ.

Int J Antimicrob Agents. 2013 Sep;42(3):202-10. doi: 10.1016/j.ijantimicag.2013.05.005. Epub 2013 Jul 8. Review.

PMID:
23845504
38.

Maximizing the impact of antimicrobial stewardship: the role of diagnostics, national and international efforts.

O'Brien DJ, Gould IM.

Curr Opin Infect Dis. 2013 Aug;26(4):352-8. doi: 10.1097/QCO.0b013e3283631046. Review.

PMID:
23806898
39.

Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).

Gould IM.

Int J Antimicrob Agents. 2013 Jun;42 Suppl:S17-21. doi: 10.1016/j.ijantimicag.2013.04.006. Epub 2013 May 8. Review.

PMID:
23664580
40.

Interventions to improve antibiotic prescribing practices for hospital inpatients.

Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, Ramsay CR, Wiffen PJ, Wilcox M.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003543. doi: 10.1002/14651858.CD003543.pub3. Review. Update in: Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543.

PMID:
23633313
41.

Comment on: Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07.

Lawes T, Edwards B, Gould IM.

J Antimicrob Chemother. 2013 Jul;68(7):1691-2. doi: 10.1093/jac/dkt070. Epub 2013 Mar 6. No abstract available.

PMID:
23471940
42.

Controlling hospital MRSA.

Gould IM.

J Glob Antimicrob Resist. 2013 Mar;1(1):43-45. doi: 10.1016/j.jgar.2013.01.006. Epub 2013 Mar 6. Review.

PMID:
27873606
43.

'The Chennai declaration': India co-ordinates action against antimicrobial resistance.

Gould IM.

J Glob Antimicrob Resist. 2013 Mar;1(1):3. doi: 10.1016/j.jgar.2013.02.002. Epub 2013 Mar 1. No abstract available.

PMID:
27873602
44.

Vancomycin in the treatment of meticillin-resistant Staphylococcus aureus (MRSA) infection: End of an era?

Bal AM, Garau J, Gould IM, Liao CH, Mazzei T, Nimmo GR, Soriano A, Stefani S, Tenover FC.

J Glob Antimicrob Resist. 2013 Mar;1(1):23-30. doi: 10.1016/j.jgar.2013.01.002. Epub 2013 Mar 1. Review.

PMID:
27873601
45.

New antibiotic agents in the pipeline and how they can help overcome microbial resistance.

Gould IM, Bal AM.

Virulence. 2013 Feb 15;4(2):185-91. doi: 10.4161/viru.22507. Epub 2013 Jan 9. Review.

46.

Antibiotics for surgical patients: the faster the better?

Noble DW, Gould IM.

Lancet Infect Dis. 2012 Oct;12(10):741-2. doi: 10.1016/S1473-3099(12)70208-6. Epub 2012 Aug 28. No abstract available.

PMID:
22951601
47.

Meticillin-resistant Staphylococcus aureus pneumonia.

Edwards B, Gould I.

Br J Hosp Med (Lond). 2012 Jul;73(7):386-91.

PMID:
22875432
48.

Impacts of a long-term programme of active surveillance and chlorhexidine baths on the clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit in Scotland.

Sangal V, Girvan EK, Jadhav S, Lawes T, Robb A, Vali L, Edwards GF, Yu J, Gould IM.

Int J Antimicrob Agents. 2012 Oct;40(4):323-31. doi: 10.1016/j.ijantimicag.2012.06.007. Epub 2012 Aug 4.

PMID:
22871372
49.

Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus.

Ludwig F, Edwards B, Lawes T, Gould IM.

J Clin Microbiol. 2012 Oct;50(10):3383-7. doi: 10.1128/JCM.01158-12. Epub 2012 Aug 1. No abstract available.

50.

Antimicrobial stewardship: lessons from human healthcare.

Edwards B, Gould IM.

Rev Sci Tech. 2012 Apr;31(1):135-44. Review.

Supplemental Content

Loading ...
Support Center